NGeneBio Co. Ltd.

NGeneBio Co., Ltd. develops in vitro diagnostics, companion diagnostics products, and bioinformatics software. Its product line includes reagent kits such as BRCAaccuTest and BRCAaccuTest PLUS for breast and ovarian cancer and hereditary breast and ovarian cancer syndrome, HEMEaccuTest for hematological malignancies, SOLIDaccuTest for genetic variant screening in solid tumors, HLAaccuTest for human leukocyte antigen typing, and OncoaccuPanel for solid tumor oncology next-generation sequencing. The company also offers NGeneAnalySys for genetic testing data analysis, EasyHLAanalyzer for HLA typing from NGS data, MTBaccuPanel for tuberculosis testing and drug-resistance mutation detection, and the NGenePlex nCoV qRT-PCR Kit for qualitative detection of SARS-CoV-2 nucleic acid. Incorporated in 2015, it is headquartered in Seoul, South Korea.